Nudicauline and elatine as potent norditerpenoid ligands at rat neuronal alpha-bungarotoxin binding sites: Importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding

被引:78
作者
Hardick, DJ
Blagbrough, IS
Cooper, G
Potter, BVL
Critchley, T
Wonnacott, S
机构
[1] UNIV BATH,SCH PHARM & PHARMACOL,DEPT MED CHEM,BATH BA2 7AY,AVON,ENGLAND
[2] UNIV BATH,SCH BIOL & BIOCHEM,BATH BA2 7AY,AVON,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1021/jm9604991
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Methyllycaconitine (MLA, 1) is a novel, potent probe for mammalian and insect nicotinic acetylcholine receptors (nAChR) and displays remarkable selectivity toward neuronal [I-125]- alpha-bungarotoxin (alpha BgTX) binding sites that correspond to alpha 7-type nAChR in mammalian brain. We have shown that, among a number of selected norditerpenoid alkaloids, elatine (2) and nudicauline (3) are equipotent with, or better than, MLA (1) in binding to brain [I-125]-alpha BgTX binding sites, with IC50 values of 6.1, 1.7, and 7.6 nM, respectively. The 2-((S)-methylsuccinimido)benzoyl moiety of these Ligands is crucial for high-affinity binding, whereas structural modifications to the norditerpenoid core of the ligand can be tolerated without loss of activity or selectivity. In addition to MLA (1), elatine (2), and nudicauline (3), we have examined lycoctonine (4), inuline (6), lappaconitine (7), N-desacetyllappaconitine (8), delsoline (10), delcorine (11), deltaline (12), condelphine (13), and karacoline (14). This study therefore extends the range of norditerpenoids, other than MLA, which can be used to probe this important class of nAChR. All 12 alkaloids were assessed for activity at [H-3]nicotine binding sites which are considered to represent alpha 4 beta 2 nAChR. Furthermore, the H-1 and C-13 NMR spectroscopic data of MLA and elatine have been critically compared.
引用
收藏
页码:4860 / 4866
页数:7
相关论文
共 36 条
[1]
ALKONDON M, 1992, MOL PHARMACOL, V41, P802
[2]
ALPHA-BUNGAROTOXIN BINDING-SITES IN RAT HIPPOCAMPAL AND CORTICAL CULTURES - INITIAL CHARACTERIZATION, COLOCALIZATION WITH ALPHA-7 SUBUNITS AND UP-REGULATION BY CHRONIC NICOTINE TREATMENT [J].
BARRANTES, GE ;
ROGERS, AT ;
LINDSTROM, J ;
WONNACOTT, S .
BRAIN RESEARCH, 1995, 672 (1-2) :228-236
[3]
STRUCTURE AND ACTIVITY OF ACETYLCHOLINE [J].
BEERS, WH ;
REICH, E .
NATURE, 1970, 228 (5275) :917-&
[4]
Benn M.H., 1983, ALKALOIDS CHEM BIOL, V1, P153
[5]
ACYLATION OF LYCOCTONINE - SEMISYNTHESIS OF INULINE, DELSEMINE ANALOGS AND METHYLLYCACONITINE [J].
BLAGBROUGH, IS ;
COATES, PA ;
HARDICK, DJ ;
LEWIS, T ;
ROWAN, MG ;
WONNACOTT, S ;
POTTER, BVL .
TETRAHEDRON LETTERS, 1994, 35 (46) :8705-8708
[6]
THE FALL AND RISE OF NEURONAL ALPHA-BUNGAROTOXIN BINDING-PROTEINS [J].
CLARKE, PBS .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (11) :407-413
[7]
An HPLC assay for the norditerpenoid alkaloid methyllycaconitine, a potent nicotinic acetylcholine receptor antagonist [J].
Coates, PA ;
Blagbrough, IS ;
Lewis, T ;
Potter, BVL ;
Rowan, MG .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (12) :1541-1544
[8]
RAPID AND EFFICIENT ISOLATION OF THE NICOTINIC RECEPTOR ANTAGONIST METHYLLYCACONITINE FROM DELPHINIUM - ASSIGNMENT OF THE METHYLSUCCINIMIDE ABSOLUTE STEREOCHEMISTRY AS S [J].
COATES, PA ;
BLAGBROUGH, IS ;
HARDICK, DJ ;
ROWAN, MG ;
WONNACOTT, S ;
POTTER, BVL .
TETRAHEDRON LETTERS, 1994, 35 (46) :8701-8704
[9]
Dale HH, 1914, J PHARMACOL EXP THER, V6, P147
[10]
METHYLLYCACONITINE - A NOVEL NICOTINIC ANTAGONIST [J].
DRASDO, A ;
CAULFIELD, M ;
BERTRAND, D ;
BERTRAND, S ;
WONNACOTT, S .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1992, 3 (03) :237-243